Entrada Therapeutics Inc.

NASDAQ: TRDA · Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT

Entrada Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
65.63M -6.68M -94.62M -51.16M
Depreciation & Amortization
3.77M 2.84M 1.9M 1.12M
Stock-Based Compensation
17.91M 13.11M 9.89M 2.53M
Other Working Capital
-122.04M 139.12M -16.4M -2.71M
Other Non-Cash Items
-10.02M -5.78M 151K 74K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-118.85M 136.31M -11.11M -3.42M
Operating Cash Flow
-41.56M 139.8M -93.79M -50.86M
Capital Expenditures
-3.16M -5.61M -2.89M -4.58M
Cash Acquisitions
n/a n/a 145.76M n/a
Purchase of Investments
-437.72M -407.21M -221.98M n/a
Sales Maturities Of Investments
413.08M 274.43M 76.21M n/a
Other Investing Acitivies
n/a n/a -145.76M n/a
Investing Cash Flow
-27.8M -138.4M -148.65M -4.58M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a 284K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.36M 1.63M 479K 939K
Financial Cash Flow
102.96M 21.04M 479K 307.46M
Net Cash Flow
33.61M 22.45M -241.96M 252.02M
Free Cash Flow
-44.72M 134.19M -96.67M -55.44M